Filter Results:
(1,299)
Show Results For
- All HBS Web
(1,299)
- People (4)
- News (227)
- Research (904)
- Events (4)
- Multimedia (7)
- Faculty Publications (496)
Show Results For
- All HBS Web
(1,299)
- People (4)
- News (227)
- Research (904)
- Events (4)
- Multimedia (7)
- Faculty Publications (496)
- 09 Oct 2020
- Blog Post
4 Things To Know About the MS/MBA Biotech
and pharmaceutical management. I learned about value-based approaches to drug pricing and concluded that overseeing a mission-driven pharmaceutical company would provide me... View Details
- March 2002 (Revised October 2005)
- Case
Wal-Mart in 2002
By: David B. Yoffie and Yusi Wang
In its first quarter of 2002, Wal-Mart became the largest company on the globe (by sales) and expanded into Japan. Was the giant retailer unstoppable? This case explores Wal-Mart's top issues in fueling top- and bottom-line growth: diversification into groceries, new... View Details
Keywords: Diversification; Expansion; Multinational Firms and Management; Corporate Strategy; Global Strategy; Retail Industry; Japan; United States
Yoffie, David B., and Yusi Wang. "Wal-Mart in 2002." Harvard Business School Case 702-466, March 2002. (Revised October 2005.)
- 01 Sep 2023
- News
Action Plan: In Context
into an enormous market opportunity for multinational corporations. “There were a lot of Chinese who felt like they needed to improve their knowledge and confidence of how to behave in these different scenarios,” Ho recalls. Ho developed... View Details
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
trials at Boston Children’s Hospital. As the founders prepare to bring their new medical device to market, they struggle with two key decisions: Should Luminopia create its own salesforce to sell its product or should it outsource? And how should the View Details
Keywords: Sean Silverthorne
- Web
2023 Reunion Presentations - Alumni
the changes have been accelerated by technology, the pandemic, rising interest rates, and inflation. But the managerial and resource-allocation implications of these developments for start-ups and established companies are often... View Details
- Web
Academics - Health Care
care organization Redesigning urgent care triage for a major academic hospital Developing a China business model for a large pharmaceutical company Cross-Registration HBS students may take graduate-level... View Details
- January 2006 (Revised April 2007)
- Case
General Electric Healthcare, 2006
By: Tarun Khanna and Elizabeth Raabe
In January 2006, Joe Hogan, head of General Electric (GE) Healthcare Technologies, prepared to step into William Castell's shoes as CEO of GE Healthcare, the world's leading manufacturer of diagnostic imaging equipment. In 2004, former CEO Jeff Immelt acquired Amersham... View Details
Keywords: Corporate Entrepreneurship; Cost vs Benefits; Growth and Development Strategy; Mergers and Acquisitions; Machinery and Machining; Global Range; Multinational Firms and Management; Product Design; Technological Innovation; Expansion; Value Creation; Business Subsidiaries; Health Industry; Medical Devices and Supplies Industry
Khanna, Tarun, and Elizabeth Raabe. "General Electric Healthcare, 2006." Harvard Business School Case 706-478, January 2006. (Revised April 2007.)
- Web
Business & Environment - Faculty & Research
volume and constituted a key lever for the company to increase its positive impact on sustainability. IKEA Group Management therefore had to decide how to manage its portfolio of wood sustainability initiatives, especially in the context... View Details
- 12 Dec 2023
- Blog Post
Bridging Science and Business: My Summer Internship at Eli Lilly
short of transformative. Far from your garden-variety "search and evaluate" teams common in Big Pharma, our team operated on a more expansive playbook. We had the exhilarating task of not only evaluating opportunities from companies... View Details
- 02 Aug 2006
- Research & Ideas
Investor Protection: The Czech Experience
drama behind the scenes, however, ultimately eclipsed the programming at TV Nova. Despite the eventual 99-percent stake held in the channel by Central European Media Enterprises (CME), the holding company of Ronald Lauder (one of the... View Details
- September 20, 2004
- Comment
How Consumers Value Global Brands
By: Douglas Holt, John A. Quelch and Earl L. Taylor
In 2002, we carried out a two-stage research project in partnership with the market research company Research International/USA to find out how consumers in different countries value global brands. First, we conducted a qualitative study in forty-one countries to... View Details
Keywords: Global Brands; Brand Value; Multi-national Brands; Social Responsibility; Global Range; Multinational Firms and Management; Globalized Markets and Industries; Brands and Branding; Social Marketing; Corporate Social Responsibility and Impact
Holt, Douglas, John A. Quelch, and Earl L. Taylor. "How Consumers Value Global Brands." Harvard Business School Working Knowledge (September 20, 2004).
- September 2001 (Revised July 2009)
- Case
Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring
By: Stuart C. Gilson and Gustavo A. Herrero
In 1998, BAESA, PepsiCo's largest bottler and distributor outside North America, experienced severe financial difficulty and had to restructure its debt and business operations to avoid bankruptcy or liquidation. Based in Argentina, with operations throughout South... View Details
Keywords: Restructuring; Borrowing and Debt; Insolvency and Bankruptcy; Bonds; Stocks; Multinational Firms and Management; Laws and Statutes; United States; Argentina; Brazil
Gilson, Stuart C., and Gustavo A. Herrero. "Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring." Harvard Business School Case 202-009, September 2001. (Revised July 2009.)
- 14 Sep 2010
- First Look
First Look: September 14, 2010
improved management and decentralization; (2) larger firms, skill-intensive plants, and foreign multinationals appear better managed and are more decentralized; (3) firms that are both family owned and managed appear to have worse... View Details
Keywords: Sean Silverthorne
- Web
Topics - HBS Working Knowledge
Stakeholder Relations (4) Business or Company Management (19) COVID-19 (127) Capital Markets (13) Capital Structure (1) Capital (65) Cash Flow (1) Cash (2) Central Banking (2) Change Management (67) Change (116) Civil Society or Community... View Details
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
necessarily contribute to overall value," Huckman says. "Think about a company that runs very profitable hospitals. Are they profitable because they've figured out how to offer high quality care at low cost? Or are they... View Details
- January 2017
- Supplement
Terrapin Laboratory: Exercise
By: Joseph B. Fuller and Christopher Payton
In this exercise, we examine the capital requirements of Terrapin Laboratory as they contemplate entering into a new market segment. The company is faced with two potential financing options which have different effects on the ownership structure of the company.... View Details
- April 2017
- Supplement
Imprimis (D)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750 per pill. Imprimis also... View Details
Keywords: Decision Choices and Conditions; Growth and Development Strategy; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (D)." Harvard Business School Supplement 717-498, April 2017.
- 11 Jan 2000
- Lessons from the Classroom
New Game, New Rules: Developing Managers for a Competitive World
large established multinationals or smaller companies expanding rapidly into overseas markets, it is imperative that participants and their sponsoring organizations view themselves as active participants in... View Details
Keywords: by Staff
- March 2015 (Revised September 2016)
- Case
Terrapin Laboratory
By: Richard G. Hamermesh and Joseph B. Fuller
Describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. The associated teaching materials provide students the opportunity... View Details
Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Growth Management; Expansion; Financing and Loans; Health Care and Treatment; Health Testing and Trials; Business Startups; Pharmaceutical Industry; Pharmaceutical Industry
Hamermesh, Richard G., and Joseph B. Fuller. "Terrapin Laboratory." Harvard Business School Case 315-098, March 2015. (Revised September 2016.)
- Web
Globalization - Faculty & Research
democracy being a substitute for economic IGOs, but a complement for social and cultural IGOs. July 2013 Article Ethnic Innovation and U.S. Multinational Firm Activity By: C. Fritz Foley and William R. Kerr This paper studies the impact... View Details